FDA panel to discuss Arena obesity drug in 2nd quarter (Reuters)

Reuters – An FDA advisory committee will meet in the second quarter to discuss Arena Pharmaceutical Inc’s experimental obesity drug following the company’s recent resubmission of an application seeking its approval, Arena said on Wednesday.